Taiho alleged that the Indian drug maker's proposed generic Lonsurf (trifluridine and tipiracil) will infringe the patent
The programme will initially commence between JPO and Indian Patent Office on pilot basis for a period of three years
Determining the proper price of patented technology is a complicated task for those not having access to market information
Also rejects a pre-grant opposition filed by a scientist while considering application
The drugmakers say their efforts have been thwarted by govt's lack of support for cheap generics